North America Nucleic Acid Isolation Purification Market
Market Size in USD Billion
CAGR :
% 
 Forecast Period |
2025 –2032 |
 Market Size (Base Year) |
USD 3.46 Billion |
 Market Size (Forecast Year) |
USD 7.65 Billion |
 CAGR |
% |
| Major Markets Players |
North America Nucleic Acid Isolation and Purification Market Segmentation, By Product (Instruments, Kits, and Reagents), Method (Magnetic Bead-Based Isolation and Purification, Column -Based Isolation and Purification, Reagent-Based Isolation and Purification, and Others), Type (Next Generation Sequencing (NGS), Genomic DNA Isolation and Purification, Total RNA Isolation and Purification, PCR Clean-Up, Plasmid DNA Isolation and Purification, Messenger RNA Isolation and Purification, Circulating Nucleic Acid Isolation and Purification, MicroRNA Isolation and Purification, and Others), Application (Diagnostics, Drug Discovery and Development, Personalized Medicine, Agriculture and Animal Research, and Others), Sample Type (FFPE Samples, Blood Cells, Bacteria, Yeast, and Plants, Cell-Free Samples, Cultured Cells, Mammalian Cells, Brain and Kidney Tissue, and Others), End User (Hospitals and Diagnostic Centers, Pharmaceutical and Biotechnology Companies, Contract Research Organizations, Contract Development and manufacturing Organization (CDMO), Academic/Research Institutes, and Others) - Industry Trends and Forecast to 2032
Nucleic Acid Isolation and Purification Market Analysis
The increasing prevalence of genetic disorders is a significant driver in the North America nucleic acid isolation and purification market, as it fuels the demand for advanced diagnostic and therapeutic solutions essential for early detection, accurate diagnosis, and personalized treatment strategies. According to a news article published by BGI Genomics, 5.2% of the global population carry hemoglobin abnormalities, resulting in 300,000 to 400,000 children born with severe hemoglobinopathies annually. The increasing number of hemoglobinopathies acts as a driver for the growth of the market.
Nucleic Acid Isolation and Purification Market Size
North America nucleic acid isolation and purification market size was valued at USD 3.46 billion in 2024 and is projected to reach USD 7.65 billion by 2032, with a CAGR of 11.0% during the forecast period of 2025 to 2032. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Nucleic Acid Isolation and Purification Market Trends
“Advancement of Automation and High-Throughput Technologies”
As the demand for faster, more efficient, and scalable nucleic acid extraction methods rises, automated systems are becoming crucial in handling large volumes of samples. These automated solutions streamline laboratory workflows, reduce manual labor, and enhance reproducibility, making them highly valuable in genomics, clinical diagnostics, and biotechnology applications. High-throughput platforms allow simultaneous processing of numerous samples, which is vital for large-scale studies, including those related to precision medicine and next-generation sequencing. Additionally, these advancements improve consistency in results, reduce the risk of human error, and accelerate research timelines. Automation also supports the growing trend of personalized medicine, enabling more efficient extraction and analysis of genetic material for individualized treatment plans. The ability to perform high-quality nucleic acid purification at scale is driving the expansion of this trend regionally.
Report Scope and Nucleic Acid Isolation and Purification Market Segmentation
|
Attributes |
Nucleic Acid Isolation and Purification Key Market Insights |
|
Segments Covered |
|
|
Countries Covered |
U.S., Canada, and Mexico |
|
Key Market Players |
Merck KGaA (Germany), Cutiva (Danaher Corporation) (U.S.), Meridian Bioscience, Inc. (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Agilent Technologies, Inc. (U.S.), PerkinElmer Inc. (U.S.), Illumina Inc. (U.S.), F. Hoffmann-La Roche Ltd. (Switzerland), Thermo Fisher Scientific Inc. (U.S.), QIAGEN (Netherlands), Takara Bio Inc. (Japan), Promega Corporation (U.S.), MACHEREY-NAGEL GmbH & Co. KG (Germany), New England Biolabs (U.S.), Omega Bio-tek, Inc. (U.S.), Zymo Research Corporation (U.S.), Analytik Jena GmbH+Co. KG (Germany), MagGenome Technologies Pvt. Ltd. (India), AUTOGEN INC. (U.S.), Xi'an Tianlong Science and Technology Co., Ltd. (China), PCR Biosystems (UK), Sage Science, Inc. (U.S.), and ALS (Australia) among others |
|
Market Opportunities |
|
|
Value Added Data Infosets |
In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework. |
Nucleic Acid Isolation and Purification Market Definition
The nucleic acid isolation and purification market refers to the sector focused on the extraction and purification of nucleic acids (DNA, RNA, and other genetic material) from biological samples for various applications, including molecular biology research, clinical diagnostics, forensic analysis, and biotechnology. This market encompasses a wide range of techniques and products such as reagent kits, automated systems, and laboratory equipment used to isolate and purify nucleic acids with high precision and efficiency. Key drivers include the growing demand for personalized medicine, advancements in genomics research, the increasing prevalence of genetic disorders, and the expansion of applications in areas like cancer research, infectious disease diagnostics, and genetic testing. The market is also influenced by technological innovations, such as Next-Generation Sequencing (NGS), which requires highly refined nucleic acid purification methods to ensure the accuracy and quality of sequencing results. The rise in research and clinical applications in emerging markets, along with the increasing number of biotechnology and pharmaceutical companies, contributes to the market’s growth.
Nucleic Acid Isolation and Purification Market Dynamics:
Drivers
- Increasing Prevalence of Genetic Disorders
The increasing prevalence of genetic disorders is a significant driver in the North America nucleic acid isolation and purification market, as it fuels the demand for advanced diagnostic and therapeutic solutions essential for early detection, accurate diagnosis, and personalized treatment strategies. As genetic disorders, including conditions such as cystic fibrosis, Huntington’s disease, and various forms of cancer, continue to affect millions worldwide, the need for precise and reliable nucleic acid isolation techniques becomes paramount. These techniques are critical for extracting high-quality DNA and RNA from patient samples, which are subsequently used in a variety of molecular diagnostics, including Next-Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), and other genomic analyses that identify genetic mutations and biomarkers. The surge in genetic research and the push towards personalized medicine necessitate robust nucleic acid purification methods to support the development of targeted therapies and gene therapies, thereby enhancing patient outcomes. The rising incidence of genetic disorders drives investments in the biotechnology and pharmaceutical sectors, leading to the expansion of laboratories and research facilities that rely on efficient nucleic acid isolation technologies. Consequently, the interplay between the rising prevalence of genetic disorders and the advancement of molecular diagnostic technologies propels the growth of the nucleic acid isolation and purification market, driving innovation, expanding market reach, and fostering North America collaborations to address the challenges posed by genetic diseases effectively.
For instance,
- In February 2024, according to an article, ‘Global distribution of β-thalassemia mutations: An update’, globally, approximately 60,000 newborns are born with the β-thalassemia major per year, with the majority living in developing countries and constituting about 1.5 % of the total population. It is the most common autosomal recessively inherited blood disorder. Hence, increasing cases of genetic disorders act as a driver in the growth of the market.
The rising occurrence of genetic disorders strongly drives the regional demand for nucleic acid isolation and purification, as these methods are essential for accurate diagnostics, early detection, and personalized treatment approaches. High-quality DNA and RNA extraction is crucial for advanced molecular analyses like NGS and PCR, which identify genetic mutations and support targeted therapies. Also, progress in genomics and gene-editing techniques heighten the need for precise purification systems that maintain genetic material integrity, fostering innovation and international collaboration to address the growing burden of genetic conditions.
- Increasing Demand for Diagnostic Testing
The growing demand for diagnostic testing is a key driver in the North America nucleic acid isolation and purification market, as more healthcare providers and researchers rely on these techniques to extract high-quality genetic material for a range of applications. Diagnostic testing for infectious diseases, cancer, genetic disorders, and other health conditions requires precise and rapid nucleic acid isolation to obtain DNA and RNA samples that enable accurate, reliable results. This demand is further fueled by the expansion of molecular diagnostics and advancements in technologies such as PCR, Next-Generation Sequencing (NGS), and CRISPR, all of which depend on purified nucleic acids for detecting pathogens, identifying mutations, and guiding personalized treatment decisions. Also, the rise in routine screening, preventive testing, and decentralized testing models such as point-of-care diagnostics has increased the volume of testing, thereby boosting the need for scalable and efficient nucleic acid isolation and purification solutions.
For instance,
- In March 2024, according to a news article published by Springer Nature, demand for diagnostic testing surges significantly with rising transmission rates and potential outbreak scenarios. High transmission settings, such as densely populated areas or environments with close-contact interactions, require frequent and rapid testing to manage virus spread effectively. As testing becomes central to early detection, contact tracing, and monitoring of infection rates, nucleic acid testing systems, particularly automated ones, are increasingly vital. The findings underscore that the demand for fast, accurate diagnostic testing will continue to grow, driven by the need for effective outbreak control and public health safety
The surge in diagnostic testing drives the nucleic acid isolation and purification market by creating a high demand for quality DNA and RNA extraction essential for accurate molecular diagnostics. With advancements in techniques like PCR and NGS and the rise in routine and point-of-care testing, the need for efficient, scalable purification methods continues to expand, supporting timely and precise disease detection and personalized care.
Opportunity
- Rise in Technological Advancements and Automation
Technological advancements and automation are driving significant growth opportunities in the North America nucleic acid isolation and purification market by enhancing accuracy, speed, and scalability in genetic research and diagnostics. Innovations like fully automated extraction systems, high-throughput sequencing, and microfluidics reduce manual intervention, minimizing human error and improving consistency in sample processing. These advancements cater to the growing demand in genomics, proteomics, and personalized medicine by enabling labs to process larger sample volumes with precision and efficiency. Automation allows for integration with downstream analysis tools, creating seamless workflows that save time and reduce costs for laboratories. This enhanced throughput capability supports the expanding applications of nucleic acid-based diagnostics, especially in oncology, infectious diseases, and genetic disorder screening. As these technologies evolve, they also facilitate real-time monitoring and remote accessibility, which are particularly beneficial for decentralized and point-of-care testing, further broadening market growth potential. As automation becomes more accessible, it opens doors for more research institutions, clinical labs, and biotechnology firms to adopt sophisticated nucleic acid isolation and purification technologies, accelerating discovery and innovation across various fields.
For instance,
- In December 2023, according to the article published by Technology Networks, Thermo Fisher Scientific Inc., a global leader in scientific services, has launched the Thermo Scientific KingFisher Apex Dx, an automated nucleic acid purification instrument, along with the Applied Biosystems MagMAX Dx Viral/Pathogen NA Isolation Kit. These products work together to enable the isolation and purification of viral and bacterial pathogens from respiratory samples. Designed for In Vitro Diagnostic (IVD) and In Vitro Diagnostic Regulation (IVD-R) compliance, these automated solutions provide laboratories with enhanced reliability for downstream testing results.
The rapid advancements in technology and automation are transforming the nucleic acid isolation and purification market by boosting accuracy, efficiency, and integration with downstream processes. These innovations enable labs to meet growing demand across genomics, diagnostics, and personalized medicine with higher throughput and reduced costs. As these technologies become more widely accessible, they expand research and diagnostic capabilities, driving broader adoption in labs and institutions worldwide ultimately accelerating progress across numerous scientific and medical fields.
Restraint/Challenge
- Risks Associated with Sample Contamination
The risk of sample contamination acts as a major restraint in the North America nucleic acid isolation and purification market, as even slight contamination can compromise the integrity and accuracy of DNA or RNA samples, leading to unreliable results. Contaminated samples may interfere with downstream applications such as Next-Generation Sequencing (NGS) or PCR, affecting diagnostics, research outcomes, and therapeutic developments. This poses significant challenges for laboratories, particularly in high-throughput settings, as contamination can increase costs, time, and resources required for retesting and validation. As a result, maintaining sample purity becomes crucial, and the need for highly reliable and contamination-free isolation systems drives continuous innovation in the market.
For instance,
- In January 2023, according to an article published by Oxford Academic, laboratory contamination had severe and widespread negative impacts on both diagnostic testing and laboratory staff. These impacts extend far beyond an individual patient’s sample, possibly jeopardizing the integrity of a multitude of patient samples and instruments.
The risk of sample contamination hinders the nucleic acid isolation and purification market by compromising the accuracy and reliability of results, leading to increased costs and delays. This challenges laboratories to maintain high standards of purity, driving demand for more reliable and contamination-resistant purification systems. The persistent concern over contamination imposes an additional burden on laboratories in terms of operational protocols and resource allocation.
Nucleic Acid Isolation and Purification Market Scope
The nucleic acid isolation and purification market is segmented on the basis of product, method, type, application, sample type, end user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Product
- Instruments
- Type
- Homogenizer
- Spectrophotometers
- Fluorometers
- Others
- Modality
- Benchtop
- Standalone
- Usability
- Automated
- Manual
- Type
- Kits
- DNA Isolation & Purification Kits
- Magnetic Bead-Based Kit
- Viral/Pathogen Nucleic Acid Isolation Kit
- Plant DNA Isolation Kit
- Cell-Free Total Nucleic Acid Kit
- Cell-Free DNA Isolation Kit
- Column-Based Kit
- Genomic DNA Purification Kit
- Viral RNA/DNA Purification Kit
- Plant DNA Purification Kit
- Microbiome DNA Purification Kit
- Others
- Reagent-Based Kit
- Magnetic Bead-Based Kit
- RNA Isolation & Purification Kits
- Magnetic Bead-Based Kit
- Viral/Pathogen Nucleic Acid Isolation Kit
- mRNA Purification Kit
- Plant RNA Isolation Kit
- Cell-Free Nucleic Acid Isolation Kit
- Others
- Column-Based Kit
- RNA Isolation Kit
- Mi RNA Isolation Kit
- Viral RNA/DNA Kit
- Reagent-Based Kit
- Magnetic Bead-Based Kit
- Viral Nucleic Acid Isolation kits
- Magnetic Bead-Based Kits
- Viral Spin-Column Kits
- Plasmid Purification Kit
- PCR and Gel kit
- Others
- DNA Isolation & Purification Kits
- Reagents
- DNA Isolation Reagent
- RNA Isolation Reagent
- Others
Method
- Magnetic Bead-Based Isolation and Purification
- Column -Based Isolation and Purification
- Reagent-Based Isolation and Purification
- Others
Type
- Next Generation Sequencing (NGS)
- Genomic DNA Isolation and Purification
- Total RNA Isolation and Purification
- PCR Clean-Up
- Plasmid DNA Isolation and Purification
- Messenger RNA Isolation and Purification
- Circulating Nucleic Acid Isolation and Purification
- MicroRNA Isolation and Purification
- Others
Application
- Diagnostics
- Instruments
- Kits
- Reagents
- Drug Discovery and Development
- Instruments
- Kits
- Reagents
- Personalized Medicine
- Instruments
- Kits
- Reagents
- Agriculture and Animal Research
- Instruments
- Kits
- Reagents
- Others
Sample Type
- FFPE Samples
- Blood Cells
- Bacteria, Yeast, and Plants
- Cell-Free Samples
- Cultured Cells
- Mammalian Cells
- Brain and Kidney Tissue
- Others
End User
- Hospitals and Diagnostic Centers
- Pharmaceutical and Biotechnology Companies
- Contract Research Organizations
- Contract Development and manufacturing Organization (CDMO)
- Academic/Research Institutes
- Others
Nucleic Acid Isolation and Purification Market Regional Analysis
The market is analyzed and market size insights and trends are provided by product, method, type, application, sample type, end user, as referenced above.
The countries covered in the market are U.S., Canada, and Mexico.
U.S. is the dominant and fastest growing country in the market due to rapid advancements in healthcare infrastructure and increased investments in research and development across the region. Also, increasing prevalence of genetic disorders, increasing demand for diagnostic testing, rising investment in genomics research and increase in launch of diagnostic products are driving the adoption.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of regional brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Nucleic Acid Isolation and Purification Market Share
The market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, regional presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to market.
Nucleic Acid Isolation and Purification Market Leaders Operating in the Market Are:
- Merck KGaA (Germany)
- Cutiva (Danaher Corporation) (U.S.)
- Meridian Bioscience, Inc. (U.S.)
- Bio-Rad Laboratories, Inc. (U.S.)
- Agilent Technologies, Inc. (U.S.)
- PerkinElmer Inc. (U.S.)
- Illumina Inc. (U.S.)
- F. Hoffmann-La Roche Ltd. (Switzerland)
- Thermo Fisher Scientific Inc. (U.S.)
- QIAGEN (Netherlands)
- Takara Bio Inc. (Japan)
- Promega Corporation (U.S.)
- MACHEREY-NAGEL GmbH & Co. KG (Germany)
- New England Biolabs (U.S.)
- Omega Bio-tek, Inc. (U.S.)
- Zymo Research Corporation (U.S.)
- Analytik Jena GmbH+Co. KG (Germany)
- MagGenome Technologies Pvt. Ltd. (India)
- AUTOGEN INC. (U.S.)
- Xi'an Tianlong Science and Technology Co., Ltd. (China)
- PCR Biosystems (UK)
- Sage Science, Inc. (U.S.)
- ALS (Australia)
Latest Developments in Nucleic Acid Isolation and Purification Market
- In August 2024, Bio-Rad had launched the VeriCheck ddPCR Empty Full Capsid Kit, designed to enhance the development of safe and effective gene therapies. This high-precision kit enables accurate quantification of viral capsids, improving research and quality control in gene therapy applications
- In May 2024, Thermo, Fisher and BRIN have partnered to enhance research capabilities in Indonesia, focusing on advancing scientific innovation and collaboration in life sciences, biotechnology, and environmental studies for local researchers
- In September 2021, PerkinElmer, Inc. has successfully completed its acquisition of BioLegend for approximately USD 5.25 billion, marking its largest acquisition to date. This strategic move enhances PerkinElmer's life sciences portfolio in areas like cytometry and proteogenomics. Leaders from both companies anticipate collaborative innovation that will drive new therapeutic discoveries and advance scientific research
- In March 2025, Medtronic announced that it had been recognized by Ethisphere, a leader in defining and advancing the standards of ethical business practices, as one of the 2025 World's Most Ethical Companies opens a new window. This helped the organization develop a brand image among other leaders
- In April 2022, GE HealthCare. announced receiving the FDA pre-market approval (PMA) for its End-tidal (Et) Control software for general anesthesia delivery on its Aisys CS2Anesthesia Delivery System. This increased the company's product portfolio and overall revenue
SKU-
Get online access to the report on the World's First Market Intelligence Cloud
- Interactive Data Analysis Dashboard
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
- Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
Table of Content
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF NORTH AMERICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET
1.4 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 DBMR TRIPOD DATA VALIDATION MODEL
2.6 MULTIVARIATE MODELLING
2.7 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.8 DBMR MARKET POSITION GRID
2.9 VENDOR SHARE ANALYSIS
2.1 MARKET END USER COVERAGE GRID
2.11 SECONDARY SOURCES
2.12 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHT
4.1 PESTAL ANALYSIS
4.2 PORTERS FIVE FORCES ANALYSIS
4.3 ADDITIONAL CUSTOMIZATION
5 NORTH AMERICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: REGULATIONS
5.1 REGULATORY AUTHORITIES IN THE ASIA-PACIFIC REGION
5.1.1 CHINA
5.1.2 AUSTRALIA
5.1.3 INDIA
5.2 NORTH AMERICA REGULATORY SCENARIO
5.2.1 U.S.
5.2.2 CANADA
5.3 EUROPE REGULATORY SCENARIO
5.4 REGULATORY SUBMISSIONS
6 MARKET OVERVIEW
6.1 DRIVERS
6.1.1 INCREASING PREVALENCE OF GENETIC DISORDERS
6.1.2 INCREASING DEMAND FOR DIAGNOSTIC TESTING
6.1.3 RISING INVESTMENT IN GENOMICS RESEARCH
6.1.4 INCREASE IN LAUNCH OF DIAGNOSTIC PRODUCTS
6.2 RESTRAINTS
6.2.1 RISKS ASSOCIATED WITH SAMPLE CONTAMINATION
6.2.2 HIGH COST OF EQUIPMENT AND REAGENTS
6.3 OPPORTUNITIES
6.3.1 RISE IN TECHNOLOGICAL ADVANCEMENTS AND AUTOMATION
6.3.2 INCREASING ADOPTION OF NEXT-GENERATION SEQUENCING (NGS)
6.3.3 GROWING APPLICATIONS IN LIQUID BIOPSY
6.4 CHALLENGES
6.4.1 TECHNICAL CHALLENGES IN SPECIFIC SAMPLE TYPES
6.4.2 ENVIRONMENTAL AND SUSTAINABILITY CONCERNS
7 NORTH AMERICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE
7.1 OVERVIEW
7.2 NEXT GENERATION SEQUENCING (NGS)
7.3 GENOMIC DNA ISOLATION AND PURIFICATION
7.4 TOTAL RNA ISOLATION AND PURIFICATION
7.5 PCR CLEAN-UP
7.6 PLASMID DNA ISOLATION AND PURIFICATION
7.7 MESSENGER RNA ISOLATION AND PURIFICATION
7.8 CIRCULATING NUCLEIC ACID ISOLATION AND PURIFICATION
7.9 MICRORNA ISOLATION AND PURIFICATION
7.1 OTHERS
8 NORTH AMERICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT
8.1 OVERVIEW
8.2 INSTRUMENTS
8.3 KITS
8.4 REAGENTS
9 NORTH AMERICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY SAMPLE TYPE
9.1 OVERVIEW
9.2 FFPE SAMPLES
9.3 BLOOD CELLS
9.4 BACTERIA, YEAST, AND PLANTS
9.5 CELL-FREE SAMPLES
9.6 CULTURED CELLS
9.7 MAMMALIAN CELLS
9.8 BRAIN AND KIDNEY TISSUE
9.9 OTHERS
10 NORTH AMERICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD
10.1 OVERVIEW
10.2 MAGNETIC BEAD-BASED ISOLATION AND PURIFICATION
10.3 COLUMN -BASED ISOLATION AND PURIFICATION
10.4 REAGENT-BASED ISOLATION AND PURIFICATION
10.5 OTHERS
11 NORTH AMERICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY APPLICATION
11.1 OVERVIEW
11.2 DIAGNOSTICS
11.3 DRUG DISCOVERY AND DEVELOPMENT
11.4 PERSONALIZED MEDICINE
11.5 AGRICULTURE AND ANIMAL RESEARCH
11.6 OTHERS
12 NORTH AMERICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY END USER
12.1 OVERVIEW
12.2 HOSPITALS AND DIAGNOSTIC CENTERS
12.3 PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES
12.4 CONTRACT RESEARCH ORGANIZATIONS
12.5 CONTRACT DEVELOPMENT AND MANUFACTURING ORGANIZATION (CDMO)
12.6 ACADEMIC/RESEARCH INSTITUTES
12.7 OTHERS
13 NORTH AMERICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY REGION
13.1 NORTH AMERICA
13.1.1 U.S.
13.1.2 CANADA
13.1.3 MEXICO
14 NORTH AMERICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: COMPANY LANDSCAPE
14.1 COMPANY SHARE ANALYSIS: NORTH AMERICA
15 SWOT ANALYSIS
16 COMPANY PROFILES
16.1 MERCK KGAA
16.1.1 COMPANY SNAPSHOT
16.1.2 REVENUE ANALYSIS
16.1.3 COMPANY SHARE ANALYSIS
16.1.4 PRODUCT PORTFOLIO
16.1.5 RECENT DEVELOPMENT
16.2 CYTIVA (DANAHER CORPORATION)
16.2.1 COMPANY SNAPSHOT
16.2.2 REVENUE
16.2.3 COMPANY SHARE ANALYSIS
16.2.4 PRODUCT PORTFOLIO
16.2.5 RECENT DEVELOPMENT
16.3 MERIDIAN BIOSCIENCE, INC.
16.3.1 COMPANY SNAPSHOT
16.3.2 COMPANY SHARE ANALYSIS
16.3.3 PRODUCT PORTFOLIO
16.3.4 RECENT DEVELOPMENT
16.4 BIO-RAD LABORATORIES, INC.
16.4.1 COMPANY SNAPSHOT
16.4.2 REVENUE ANALYSIS
16.4.3 COMPANY SHARE ANALYSIS
16.4.4 PRODUCT PORTFOLIO
16.4.5 RECENT DEVELOPMENT
16.5 AGILENT TECHNOLOGIES, INC.
16.5.1 COMPANY SNAPSHOT
16.5.2 REVENUE ANALYSIS
16.5.3 COMPANY SHARE ANALYSIS
16.5.4 PRODUCT PORTFOLIO
16.5.5 RECENT UPDATES
16.6 AUTOGEN, INC.
16.6.1 COMPANY SNAPSHOT
16.6.2 PRODUCT PORTFOLIO
16.6.3 RECENT DEVELOPMENT
16.7 ALS
16.7.1 COMPANY SNAPSHOT
16.7.2 PRODUCT PORTFOLIO
16.7.3 RECENT DEVELOPMENTS
16.8 ANALYTIK JENA GMBH+CO. KG
16.8.1 COMPANY SNAPSHOT
16.8.2 PRODUCT PORTFOLIO
16.8.3 RECENT DEVELOPMENT
16.9 F. HOFFMANN-LA ROCHE LTD.
16.9.1 COMPANY SNAPSHOT
16.9.2 REVENUE ANALYSIS
16.9.3 PRODUCT PORTFOLIO
16.9.4 RECENT DEVELOPMENT
16.1 ILLUMINA, INC.
16.10.1 COMPANY SNAPSHOT
16.10.2 REVENUE ANALYSIS
16.10.3 PRODUCT PORTFOLIO
16.10.4 RECENT DEVELOPMENT
16.11 MAGGENOME TECHNOLOGIES PVT. LTD.
16.11.1 COMPANY SNAPSHOT
16.11.2 PRODUCT PORTFOLIO
16.11.3 RECENT DEVELOPMENT
16.12 MACHEREY-NAGEL GMBH & CO. KG
16.12.1 COMPANY SNAPSHOT
16.12.2 PRODUCT PORTFOLIO
16.12.3 RECENT DEVELOPMENT
16.13 NEW ENGLAND BIOLABS
16.13.1 COMPANY SNAPSHOT
16.13.2 PRODUCT PORTFOLIO
16.13.3 RECENT DEVELOPMENT
16.14 OMEGA BIO-TEK, INC.
16.14.1 COMPANY SNAPSHOT
16.14.2 PRODUCT PORTFOLIO
16.14.3 RECENT DEVELOPMENTS
16.15 PROMEGA CORPORATION
16.15.1 COMPANY SNAPSHOT
16.15.2 PRODUCT PORTFOLIO
16.15.3 RECENT DEVELOPMENT
16.16 PERKINELMER INC
16.16.1 COMPANY SNAPSHOT
16.16.2 REVENUE ANALYSIS
16.16.3 PRODUCT PORTFOLIO
16.16.4 RECENT DEVELOPMENT
16.17 PCR BIOSYSTEMS
16.17.1 COMPANY SNAPSHOT
16.17.2 PRODUCT PORTFOLIO
16.17.3 RECENT DEVELOPMENTS
16.18 QIAGEN
16.18.1 COMPANY SNAPSHOT
16.18.2 REVENUE ANALYSIS
16.18.3 PRODUCT PORTFOLIO
16.18.4 RECENT DEVELOPMENTS
16.19 SAGE SCIENCE, INC.
16.19.1 COMPANY SNAPSHOT
16.19.2 PRODUCT PORTFOLIO
16.19.3 RECENT DEVELOPMENTS
16.2 THERMO FISHER SCIENTIFIC INC.
16.20.1 COMPANY SNAPSHOT
16.20.2 REVENUE ANALYSIS
16.20.3 PRODUCT PORTFOLIO
16.20.4 RECENT DEVELOPMENT
16.21 TAKARA BIO INC.
16.21.1 COMPANY SNAPSHOT
16.21.2 REVENUE ANALYSIS
16.21.3 PRODUCT PORTFOLIO
16.21.4 RECENT DEVELOPMENTS
16.22 XI'AN TIANLONG SCIENCE AND TECHNOLOGY CO., LTD
16.22.1 COMPANY SNAPSHOT
16.22.2 PRODUCT PORTFOLIO
16.22.3 RECENT DEVELOPMENT
16.23 ZYMO RESEARCH CORPORATION
16.23.1 COMPANY SNAPSHOT
16.23.2 PRODUCT PORTFOLIO
16.23.3 RECENT DEVELOPMENT
17 QUESTIONNAIRE
18 RELATED REPORTS
List of Table
TABLE 1 NORTH AMERICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 2 NORTH AMERICA NEXT GENERATION SEQUENCING (NGS) IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 3 NORTH AMERICA GENOMIC DNA ISOLATION AND PURIFICATION IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 4 NORTH AMERICA TOTAL RNA ISOLATION AND PURIFICATION IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 5 NORTH AMERICA PCR CLEAN-UP IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 6 NORTH AMERICA PLASMID DNA ISOLATION AND PURIFICATION IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 7 NORTH AMERICA MESSENGER RNA ISOLATION AND PURIFICATION IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 8 NORTH AMERICA CIRCULATING NUCLEIC ACID ISOLATION AND PURIFICATION IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 9 NORTH AMERICA MICRORNA ISOLATION AND PURIFICATION IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 10 NORTH AMERICA OTHERS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 11 NORTH AMERICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT, 2018-2032 (USD THOUSAND)
TABLE 12 NORTH AMERICA INSTRUMENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 13 NORTH AMERICA INSTRUMENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 14 NORTH AMERICA INSTRUMENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 15 NORTH AMERICA INSTRUMENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY MODALITY, 2018-2032 (USD THOUSAND)
TABLE 16 NORTH AMERICA INSTRUMENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY USABILITY, 2018-2032 (USD THOUSAND)
TABLE 17 NORTH AMERICA KITS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 18 NORTH AMERICA KITS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 19 NORTH AMERICA DNA ISOLATION & PURIFICATION KITS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 20 NORTH AMERICA MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 21 NORTH AMERICA MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 22 NORTH AMERICA COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 23 NORTH AMERICA COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 24 NORTH AMERICA RNA ISOLATION & PURIFICATION KITS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 25 NORTH AMERICA MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 26 NORTH AMERICA MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 27 NORTH AMERICA COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 28 NORTH AMERICA COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 29 NORTH AMERICA VIRAL NUCLEIC ACID ISOLATION KITS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 30 NORTH AMERICA VIRAL NUCLEIC ACID ISOLATION KITS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 31 NORTH AMERICA REAGENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 32 NORTH AMERICA REAGENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 33 NORTH AMERICA REAGENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 34 NORTH AMERICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY SAMPLE TYPE, 2018-2032 (USD THOUSAND)
TABLE 35 NORTH AMERICA FFPE SAMPLES IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 36 NORTH AMERICA BLOOD CELLS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 37 NORTH AMERICA BACTERIA, YEAST, AND PLANTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 38 NORTH AMERICA CELL-FREE SAMPLES IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 39 NORTH AMERICA CULTURED CELLS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 40 NORTH AMERICA MAMMALIAN CELLS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 41 NORTH AMERICA BRAIN AND KIDNEY TISSUE IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 42 NORTH AMERICA OTHERS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 43 NORTH AMERICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD, 2018-2032 (USD THOUSAND)
TABLE 44 NORTH AMERICA MAGNETIC BEAD-BASED ISOLATION AND PURIFICATION IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 45 NORTH AMERICA COLUMN-BASED ISOLATION AND PURIFICATION IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 46 NORTH AMERICA REAGENT-BASED ISOLATION AND PURIFICATION IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 47 NORTH AMERICA OTHERS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 48 NORTH AMERICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY APPLICATION, 2018-2032 (USD THOUSAND)
TABLE 49 NORTH AMERICA DIAGNOSTICS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 50 NORTH AMERICA DIAGNOSTICS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 51 NORTH AMERICA DRUG DISCOVERY AND DEVELOPMENT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 52 NORTH AMERICA DRUG DISCOVERY AND DEVELOPMENT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 53 NORTH AMERICA INSTRUMENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 54 NORTH AMERICA PERSONALIZED MEDICINE IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 55 NORTH AMERICA AGRICULTURE AND ANIMAL RESEARCH IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 56 NORTH AMERICA AGRICULTURE AND ANIMAL RESEARCH IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 57 NORTH AMERICA OTHERS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 58 NORTH AMERICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY END USER, 2018-2032 (USD THOUSAND)
TABLE 59 NORTH AMERICA HOSPITALS AND DIAGNOSTIC CENTERS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 60 NORTH AMERICA PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 61 NORTH AMERICA CONTRACT RESEARCH ORGANIZATIONS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 62 NORTH AMERICA CONTRACT DEVELOPMENT AND MANUFACTURING ORGANIZATION (CDMO) IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 63 NORTH AMERICA ACADEMIC/RESEARCH INSTITUTES IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 64 NORTH AMERICA OTHERS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 65 NORTH AMERICA INSTRUMENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 66 NORTH AMERICA INSTRUMENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 67 NORTH AMERICA INSTRUMENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)
TABLE 68 NORTH AMERICA INSTRUMENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY MODALITY, 2018-2032 (USD THOUSAND)
TABLE 69 NORTH AMERICA INSTRUMENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY USABILITY, 2018-2032 (USD THOUSAND)
TABLE 70 NORTH AMERICA KITS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 71 NORTH AMERICA DNA ISOLATION & PURIFICATION KITS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 72 NORTH AMERICA MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 73 NORTH AMERICA MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 74 NORTH AMERICA MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)
TABLE 75 NORTH AMERICA COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 76 NORTH AMERICA COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 77 NORTH AMERICA COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)
TABLE 78 NORTH AMERICA RNA ISOLATION & PURIFICATION KITS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 79 NORTH AMERICA MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 80 NORTH AMERICA MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 81 NORTH AMERICA MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)
TABLE 82 NORTH AMERICA COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 83 NORTH AMERICA COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 84 NORTH AMERICA COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)
TABLE 85 NORTH AMERICA VIRAL NUCLEIC ACID ISOLATION KITS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 86 NORTH AMERICA VIRAL NUCLEIC ACID ISOLATION KITS IN NUCLEIC ACID ISOLATION, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 87 NORTH AMERICA VIRAL NUCLEIC ACID ISOLATION KITS IN NUCLEIC ACID ISOLATION, BY TYPE, 2018-2032 (ASP)
TABLE 88 NORTH AMERICA REAGENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 89 NORTH AMERICA REAGENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 90 NORTH AMERICA REAGENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)
TABLE 91 NORTH AMERICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD, 2018-2032 (USD THOUSAND)
TABLE 92 NORTH AMERICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 93 NORTH AMERICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY APPLICATION, 2018-2032 (USD THOUSAND)
TABLE 94 NORTH AMERICA DIAGNOSTICS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 95 NORTH AMERICA DRUG DISCOVERY AND DEVELOPMENT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 96 NORTH AMERICA PERSONALIZED MEDICINE IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 97 NORTH AMERICA AGRICULTURE AND ANIMAL RESEARCH IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 98 NORTH AMERICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY SAMPLE TYPE, 2018-2032 (USD THOUSAND)
TABLE 99 NORTH AMERICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY END USER, 2018-2032 (USD THOUSAND)
TABLE 100 U.S. NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT, 2018-2032 (USD THOUSAND)
TABLE 101 U.S. INSTRUMENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 102 U.S. INSTRUMENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 103 U.S. INSTRUMENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)
TABLE 104 U.S. INSTRUMENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY MODALITY, 2018-2032 (USD THOUSAND)
TABLE 105 U.S. INSTRUMENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY USABILITY, 2018-2032 (USD THOUSAND)
TABLE 106 U.S. KITS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 107 U.S. DNA ISOLATION & PURIFICATION KITS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 108 U.S. MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 109 U.S. MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 110 U.S. MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)
TABLE 111 U.S. COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 112 U.S. COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 113 U.S. COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)
TABLE 114 U.S. RNA ISOLATION & PURIFICATION KITS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 115 U.S. MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 116 U.S. MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 117 U.S. MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)
TABLE 118 U.S. COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 119 U.S. COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 120 U.S. COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)
TABLE 121 U.S. VIRAL NUCLEIC ACID ISOLATION KITS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 122 U.S. VIRAL NUCLEIC ACID ISOLATION KITS IN NUCLEIC ACID ISOLATION, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 123 U.S. VIRAL NUCLEIC ACID ISOLATION KITS IN NUCLEIC ACID ISOLATION, BY TYPE, 2018-2032 (ASP)
TABLE 124 U.S. REAGENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 125 U.S. REAGENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 126 U.S. REAGENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)
TABLE 127 U.S. NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD, 2018-2032 (USD THOUSAND)
TABLE 128 U.S. NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 129 U.S. NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY APPLICATION, 2018-2032 (USD THOUSAND)
TABLE 130 U.S. DIAGNOSTICS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 131 U.S. DRUG DISCOVERY AND DEVELOPMENT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 132 U.S. PERSONALIZED MEDICINE IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 133 U.S. AGRICULTURE AND ANIMAL RESEARCH IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 134 U.S. NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY SAMPLE TYPE, 2018-2032 (USD THOUSAND)
TABLE 135 U.S. NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY END USER, 2018-2032 (USD THOUSAND)
TABLE 136 CANADA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT, 2018-2032 (USD THOUSAND)
TABLE 137 CANADA INSTRUMENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 138 CANADA INSTRUMENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 139 CANADA INSTRUMENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)
TABLE 140 CANADA INSTRUMENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY MODALITY, 2018-2032 (USD THOUSAND)
TABLE 141 CANADA INSTRUMENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY USABILITY, 2018-2032 (USD THOUSAND)
TABLE 142 CANADA KITS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 143 CANADA DNA ISOLATION & PURIFICATION KITS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 144 CANADA MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 145 CANADA MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 146 CANADA MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)
TABLE 147 CANADA COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 148 CANADA COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 149 CANADA COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)
TABLE 150 CANADA RNA ISOLATION & PURIFICATION KITS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 151 CANADA MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 152 CANADA MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 153 CANADA MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)
TABLE 154 CANADA COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 155 CANADA COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 156 CANADA COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)
TABLE 157 CANADA VIRAL NUCLEIC ACID ISOLATION KITS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 158 CANADA VIRAL NUCLEIC ACID ISOLATION KITS IN NUCLEIC ACID ISOLATION, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 159 CANADA VIRAL NUCLEIC ACID ISOLATION KITS IN NUCLEIC ACID ISOLATION, BY TYPE, 2018-2032 (ASP)
TABLE 160 CANADA REAGENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 161 CANADA REAGENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 162 CANADA REAGENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)
TABLE 163 CANADA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD, 2018-2032 (USD THOUSAND)
TABLE 164 CANADA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 165 CANADA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY APPLICATION, 2018-2032 (USD THOUSAND)
TABLE 166 CANADA DIAGNOSTICS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 167 CANADA DRUG DISCOVERY AND DEVELOPMENT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 168 CANADA PERSONALIZED MEDICINE IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 169 CANADA AGRICULTURE AND ANIMAL RESEARCH IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 170 CANADA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY SAMPLE TYPE, 2018-2032 (USD THOUSAND)
TABLE 171 CANADA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY END USER, 2018-2032 (USD THOUSAND)
TABLE 172 MEXICO NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT, 2018-2032 (USD THOUSAND)
TABLE 173 MEXICO INSTRUMENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 174 MEXICO INSTRUMENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 175 MEXICO INSTRUMENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)
TABLE 176 MEXICO INSTRUMENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY MODALITY, 2018-2032 (USD THOUSAND)
TABLE 177 MEXICO INSTRUMENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY USABILITY, 2018-2032 (USD THOUSAND)
TABLE 178 MEXICO KITS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 179 MEXICO DNA ISOLATION & PURIFICATION KITS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 180 MEXICO MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 181 MEXICO MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 182 MEXICO MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)
TABLE 183 MEXICO COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 184 MEXICO COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 185 MEXICO COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)
TABLE 186 MEXICO RNA ISOLATION & PURIFICATION KITS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 187 MEXICO MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 188 MEXICO MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 189 MEXICO MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)
TABLE 190 MEXICO COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 191 MEXICO COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 192 MEXICO COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)
TABLE 193 MEXICO VIRAL NUCLEIC ACID ISOLATION KITS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 194 MEXICO VIRAL NUCLEIC ACID ISOLATION KITS IN NUCLEIC ACID ISOLATION, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 195 MEXICO VIRAL NUCLEIC ACID ISOLATION KITS IN NUCLEIC ACID ISOLATION, BY TYPE, 2018-2032 (ASP)
TABLE 196 MEXICO REAGENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 197 MEXICO REAGENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 198 MEXICO REAGENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)
TABLE 199 MEXICO NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD, 2018-2032 (USD THOUSAND)
TABLE 200 MEXICO NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 201 MEXICO NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY APPLICATION, 2018-2032 (USD THOUSAND)
TABLE 202 MEXICO DIAGNOSTICS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 203 MEXICO DRUG DISCOVERY AND DEVELOPMENT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 204 MEXICO PERSONALIZED MEDICINE IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 205 MEXICO AGRICULTURE AND ANIMAL RESEARCH IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 206 MEXICO NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY SAMPLE TYPE, 2018-2032 (USD THOUSAND)
TABLE 207 MEXICO NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY END USER, 2018-2032 (USD THOUSAND)
List of Figure
FIGURE 1 NORTH AMERICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: SEGMENTATION
FIGURE 2 NORTH AMERICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: DATA TRIANGULATION
FIGURE 3 NORTH AMERICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: DROC ANALYSIS
FIGURE 4 NORTH AMERICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: NORTH AMERICA VS REGIONAL MARKET ANALYSIS
FIGURE 5 NORTH AMERICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 NORTH AMERICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: MULTIVARIATE MODELLING
FIGURE 7 NORTH AMERICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 8 NORTH AMERICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: DBMR MARKET POSITION GRID
FIGURE 9 NORTH AMERICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: VENDOR SHARE ANALYSIS
FIGURE 10 NORTH AMERICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: MARKET END USER COVERAGE GRID
FIGURE 11 NORTH AMERICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: SEGMENTATION
FIGURE 12 THREE SEGMENTS COMPRISE THE NORTH AMERICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT
FIGURE 13 EXECUTIVE SUMMARY
FIGURE 14 STRATEGIC DECISIONS
FIGURE 15 INCREASING PREVALENCE OF GENERIC DISORDERS AND RISING INVESTMENT IN GENOMICS RESEARCH ARE PROJECTED TO EXPAND THE SCOPE OF NORTH AMERICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET
FIGURE 16 INSTRUMENTS SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE NORTH AMERICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET IN 2025 & 2032
FIGURE 17 RNA ISOLATION & PURIFICATION KITS
FIGURE 18 DNA ISOLATION & PURIFICATION KITS
FIGURE 19 VIRAL NUCLEIC ACID ISOLATION KITS
FIGURE 20 PLASMID PURIFICATION KITS
FIGURE 21 PCR AND GEL CLEAN UP KITS
FIGURE 22 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES FOR NORTH AMERICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET
FIGURE 23 NORTH AMERICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: BY TYPE, 2024
FIGURE 24 NORTH AMERICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: BY TYPE, 2025-2032 (USD THOUSAND)
FIGURE 25 NORTH AMERICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: BY TYPE, CAGR (2025-2032)
FIGURE 26 NORTH AMERICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: BY TYPE, LIFELINE CURVE
FIGURE 27 NORTH AMERICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: BY PRODUCT, 2024
FIGURE 28 NORTH AMERICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: BY PRODUCT, 2025-2032 (USD THOUSAND)
FIGURE 29 NORTH AMERICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: BY PRODUCT, CAGR (2025-2032)
FIGURE 30 NORTH AMERICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: BY PRODUCT, LIFELINE CURVE
FIGURE 31 NORTH AMERICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: BY SAMPLE TYPE, 2024
FIGURE 32 NORTH AMERICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: BY SAMPLE TYPE, 2025-2032 (USD THOUSAND)
FIGURE 33 NORTH AMERICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: BY SAMPLE TYPE, CAGR (2025-2032)
FIGURE 34 NORTH AMERICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: BY SAMPLE TYPE, LIFELINE CURVE
FIGURE 35 NORTH AMERICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: BY METHOD, 2024
FIGURE 36 NORTH AMERICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: BY METHOD, 2025-2032 (USD THOUSAND)
FIGURE 37 NORTH AMERICA ANTI- NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: BY METHOD, CAGR (2025-2032)
FIGURE 38 NORTH AMERICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: BY METHOD, LIFELINE CURVE
FIGURE 39 NORTH AMERICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: BY APPLICATION, 2024
FIGURE 40 NORTH AMERICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: BY APPLICATION, 2025-2032 (USD THOUSAND)
FIGURE 41 NORTH AMERICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: BY APPLICATION, CAGR (2025-2032)
FIGURE 42 NORTH AMERICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: BY APPLICATION, LIFELINE CURVE
FIGURE 43 NORTH AMERICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: BY END USER, 2024
FIGURE 44 NORTH AMERICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: BY END USER, 2025-2032 (USD THOUSAND)
FIGURE 45 NORTH AMERICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: BY END USER, CAGR (2025-2032)
FIGURE 46 NORTH AMERICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: BY END USER, LIFELINE CURVE
FIGURE 47 NORTH AMERICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: SNAPSHOT (2024)
FIGURE 48 NORTH AMERICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: COMPANY SHARE 2024 (%)
Research Methodology
Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
Customization Available
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.
